What are the three predominant influences on price elasticity?

The Department of Health and Human Services regulations, which include among the conditions illustrative of physical impairments covered by the Act "cosmetic disfigurement," lend further support to Arline's position that the effects of one's impairment on others is as relevant to a determination of whether one is handicapped as is the physical effect of one's handicap on oneself. 45 CFR 84.3(j)(2)(i)(A) (1985). At oral argument, the United States took the position that a condition such as cosmetic disfigurement could not substantially limit a major life activity within the meaning of the statute, because the only major life activity that it would affect would be the ability to work. The United States recognized that "working" was one of the major life activities listed in the regulations, but said that to argue that a condition that impairedonlythe ability to work was a handicapping condition was to make "a totally circular argument which lifts itself by its bootstrap

Question 1

What is the maintenance dose of phenytoin in seizures arising as a

complication of chronic renal failure?

Question 2

I know that the loading dose of phenytoin in status epilepticus is

20 mg/kg with an upper limit of 1000 mg but if the same situation arose

as a complication of chronic renal failure (on regular dialysis), should

this dose remain the same or be reduced? If reduced, what should the

dose be?

Question 3

1. What is the most effective antiepileptic for a patient with simple

partial motor status epilepticus who is not responding to a loading

dose of phenytoin?

2. How long does phenytoin, given in a loading dose, take to work?

Question 4

Is valproate effective if given rectally in status epilepticus and, if so, what

dose is recommended?

Question 5

In simple partial motor status epilepticus, if the patient does not respond

to diazepam and phenytoin, is it justifiable to proceed to anaesthetic

medication?

Question 6

What is the recommended upper limit dose of lamotrigine when

combined with both carbamazepine and valproate?

Question 7

Is a valproate-lamotrigine combination more effective than

carbamazepine on its own against partial seizures?

Question 8

Why is the incidence of parkinsonism less common in smokers?

Question 9

Is it recommended to start the treatment of parkinsonism with dopamine

agonists alone in elderly (over 60 years old) patients, and to delay using

L-dopa until the disease has progressed much further? Is there a rationale

for this protocol in younger patients?

Question 10

Does amantadine increase the endogenous release of dopamine, thus

aiding early treatment of parkinsonism?